Primary breast-cancer
Oestrogen receptor negative early operable primary breast cancer in older women—biological characteristics and long term clinical outcome
12
Expression of Androgen receptor in primary Breast Cancer.
147
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast conservation surgery, with or without postoperative radiotherapy
11
Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism
15
Expression and clinicopathological significance of fsip1 in breast cancer
9
ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway
15
PubMedCentral-PMC5140046.pdf
20
Critical analysis of the potential for microRNA biomarkers in breast cancer management
21
Risk of second primary cancer in men with breast cancer
7
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth
13
Options for early breast cancer follow up in primary and secondary care : a systematic review
13
Human breast cancer cell lines contain stem like cells that self renew, give rise to phenotypically diverse progeny and survive chemotherapy
13
p53 protein accumulation predicts resistance to endocrine therapy and decreased post relapse survival in metastatic breast cancer
8
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
36
Breast cancer cells obtain an osteomimetic feature via epithelial- mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction
18
Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment
10
Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study
12
Stat3 is tyrosine phosphorylated through the interleukin 6/glycoprotein 130/Janus kinase pathway in breast cancer
8
DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells
12
miR-20b is up-regulated in brain metastases from primary breast cancers
8